AbbVie Inc. (ABBV)
FDA Applications
Note: This list only includes applications that have been responded to by the FDA.
| Application | Product Name | Active Ingredient | Form | Strength | Status | ||
|---|---|---|---|---|---|---|---|
| BLA761262 - ABBVIE INC | |||||||
| SKYRIZI | RISANKIZUMAB-RZAA | INJECTABLE;INTRAVENOUS | 600MG/VIAL | Prescription | |||
| BLA761105 - ABBVIE INC | |||||||
| SKYRIZI | RISANKIZUMAB-RZAA | INJECTABLE;INJECTION | 75MG/0.83ML | Prescription | |||
| SKYRIZI | RISANKIZUMAB-RZAA | INJECTABLE;INJECTION | 150MG/ML | Prescription | |||
| NDA218347 - ABBVIE | |||||||
| RINVOQ | UPADACITINIB | TABLET, EXTENDED RELEASE;ORAL | 15MG | Prescription | |||
| RINVOQ | UPADACITINIB | TABLET, EXTENDED RELEASE;ORAL | 30MG | Prescription | |||
| RINVOQ | UPADACITINIB | TABLET, EXTENDED RELEASE;ORAL | 45MG | Prescription | |||
| RINVOQ LQ | UPADACITINIB | SOLUTION;ORAL | 1MG/ML | Prescription | |||
| NDA216962 - ABBVIE | |||||||
| VYALEV | FOSCARBIDOPA; FOSLEVODOPA | SOLUTION;SUBCUTANEOUS | 120MG/10ML;2400MG/10ML (12MG/ML;240MG/ML) | Prescription | |||
| NDA215206 - ABBVIE | |||||||
| QULIPTA | ATOGEPANT | TABLET;ORAL | 60MG | Prescription | |||
| QULIPTA | ATOGEPANT | TABLET;ORAL | 10MG | Prescription | |||
| QULIPTA | ATOGEPANT | TABLET;ORAL | 30MG | Prescription | |||
| NDA215110 - ABBVIE | |||||||
| MAVYRET | GLECAPREVIR; PIBRENTASVIR | PELLETS;ORAL | 50MG;20MG/PACKET | Prescription | |||
| NDA214660 - ABBVIE INC | |||||||
| NDA214028 - ABBVIE | |||||||
| VUITY | PILOCARPINE HYDROCHLORIDE | SOLUTION;OPHTHALMIC | 1.25% | Prescription | |||
| NDA213388 - ABBVIE | |||||||
| ORIAHNN (COPACKAGED) | ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE; ELAGOLIX SODIUM | CAPSULE;ORAL | EQ 300MG BASE,1MG,0.5MG; EQ 300MG BASE | Prescription | |||
| NDA211911 - ABBVIE | |||||||
| DURYSTA | BIMATOPROST | IMPLANT;OPHTHALMIC | 10MCG | Prescription | |||
| NDA211765 - ABBVIE | |||||||
| UBRELVY | UBROGEPANT | TABLET;ORAL | 50MG | Prescription | |||
| UBRELVY | UBROGEPANT | TABLET;ORAL | 100MG | Prescription | |||
| NDA211675 - ABBVIE | |||||||
| RINVOQ | UPADACITINIB | TABLET, EXTENDED RELEASE;ORAL | 45MG | Prescription | |||
| RINVOQ | UPADACITINIB | TABLET, EXTENDED RELEASE;ORAL | 30MG | Prescription | |||
| RINVOQ | UPADACITINIB | TABLET, EXTENDED RELEASE;ORAL | 15MG | Prescription | |||
| NDA210450 - ABBVIE | |||||||
| ORILISSA | ELAGOLIX SODIUM | TABLET;ORAL | EQ 200MG BASE | Prescription | |||
| ORILISSA | ELAGOLIX SODIUM | TABLET;ORAL | EQ 150MG BASE | Prescription | |||
| NDA209512 - ABBVIE | |||||||
| NORVIR | RITONAVIR | POWDER;ORAL | 100MG/PACKET | Prescription | |||
| NDA209394 - ABBVIE | |||||||
| MAVYRET | GLECAPREVIR; PIBRENTASVIR | TABLET;ORAL | 100MG;40MG | Prescription | |||
| NDA208624 - ABBVIE | |||||||
| VIEKIRA XR | DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR | TABLET, EXTENDED RELEASE;ORAL | EQ 200MG BASE;8.33MG;50MG;33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA208573 - ABBVIE | |||||||
| VENCLEXTA | VENETOCLAX | TABLET;ORAL | 10MG | Prescription | |||
| VENCLEXTA | VENETOCLAX | TABLET;ORAL | 100MG | Prescription | |||
| VENCLEXTA | VENETOCLAX | TABLET;ORAL | 50MG | Prescription | |||
| NDA207931 - ABBVIE | |||||||
| TECHNIVIE | OMBITASVIR; PARITAPREVIR; RITONAVIR | TABLET;ORAL | 12.5MG;75MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA206940 - ABBVIE | |||||||
| VIBERZI | ELUXADOLINE | TABLET;ORAL | 75MG | Prescription | |||
| VIBERZI | ELUXADOLINE | TABLET;ORAL | 100MG | Prescription | |||
| NDA206619 - ABBVIE | |||||||
| VIEKIRA PAK (COPACKAGED) | DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR | TABLET;ORAL | EQ 250MG BASE;12.5MG, 75MG, 50MG | Discontinued | |||
| NDA206494 - ABBVIE | |||||||
| AVYCAZ | AVIBACTAM SODIUM; CEFTAZIDIME | POWDER;INTRAVENOUS | EQ 0.5GM BASE;2GM/VIAL | Prescription | |||
| NDA206439 - ALLERGAN | |||||||
| NAMZARIC | DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 10MG;14MG | Prescription | |||
| NAMZARIC | DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 10MG;28MG | Prescription | |||
| NAMZARIC | DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 10MG;7MG | Prescription | |||
| NAMZARIC | DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 10MG;21MG | Prescription | |||
| NDA206333 - ABBVIE | |||||||
| KYBELLA | DEOXYCHOLIC ACID | SOLUTION;SUBCUTANEOUS | 20MG/2ML (10MG/ML) | Prescription | |||
| NDA206302 - ABBVIE | |||||||
| BYVALSON | NEBIVOLOL HYDROCHLORIDE; VALSARTAN | TABLET;ORAL | EQ 5MG BASE;80MG | Discontinued | |||
| NDA204412 - ABBVIE | |||||||
| DELZICOL | MESALAMINE | CAPSULE, DELAYED RELEASE;ORAL | 400MG | Prescription | |||
| NDA204370 - ABBVIE | |||||||
| VRAYLAR | CARIPRAZINE HYDROCHLORIDE | CAPSULE;ORAL | EQ 1.5MG BASE | Prescription | |||
| VRAYLAR | CARIPRAZINE HYDROCHLORIDE | CAPSULE;ORAL | EQ 4.5MG BASE | Prescription | |||
| VRAYLAR | CARIPRAZINE HYDROCHLORIDE | CAPSULE;ORAL | EQ 6MG BASE | Prescription | |||
| VRAYLAR | CARIPRAZINE HYDROCHLORIDE | CAPSULE;ORAL | EQ 3MG BASE | Prescription | |||
| NDA204168 - ABBVIE | |||||||
| FETZIMA | LEVOMILNACIPRAN HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | EQ 40MG BASE | Prescription | |||
| FETZIMA | LEVOMILNACIPRAN HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | EQ 120MG BASE | Prescription | |||
| FETZIMA | LEVOMILNACIPRAN HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | EQ 20MG BASE | Prescription | |||
| FETZIMA | LEVOMILNACIPRAN HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | EQ 80MG BASE | Prescription | |||
| NDA203952 - ABBVIE | |||||||
| DUOPA | CARBIDOPA; LEVODOPA | SUSPENSION;ENTERAL | 4.63MG/ML;20MG/ML | Prescription | |||
| NDA203696 - ABBVIE ENDOCRINE | |||||||
| LUPANETA PACK | LEUPROLIDE ACETATE; NORETHINDRONE ACETATE | INJECTABLE, TABLET;INTRAMUSCULAR, ORAL | 3.75MG/VIAL,N/A;N/A,5MG | Discontinued | |||
| LUPANETA PACK | LEUPROLIDE ACETATE; NORETHINDRONE ACETATE | INJECTABLE, TABLET;INTRAMUSCULAR, ORAL | 11.25MG/VIAL,N/A;N/A,5MG | Discontinued | |||
| NDA202811 - ABBVIE | |||||||
| LINZESS | LINACLOTIDE | CAPSULE;ORAL | 290MCG | Prescription | |||
| LINZESS | LINACLOTIDE | CAPSULE;ORAL | 145MCG | Prescription | |||
| LINZESS | LINACLOTIDE | CAPSULE;ORAL | 72MCG | Prescription | |||
| NDA202211 - ABBVIE | |||||||
| OXYTROL FOR WOMEN | OXYBUTYNIN | FILM, EXTENDED RELEASE;TRANSDERMAL | 3.9MG/24HR | Over-the-counter | |||
| NDA200327 - ABBVIE | |||||||
| TEFLARO | CEFTAROLINE FOSAMIL | POWDER;INTRAVENOUS | 600MG/VIAL | Prescription | |||
| TEFLARO | CEFTAROLINE FOSAMIL | POWDER;INTRAVENOUS | 400MG/VIAL | Prescription | |||
| BLA125057 - ABBVIE INC | |||||||
| HUMIRA | ADALIMUMAB | VIAL | 40MG/0.8ML | Prescription | |||
| HUMIRA | ADALIMUMAB | SYRINGE | 40MG/0.8ML | Prescription | |||
| ANDA089736 - ABBVIE | |||||||
| VICODIN ES | ACETAMINOPHEN; HYDROCODONE BITARTRATE | TABLET;ORAL | 750MG;7.5MG | Discontinued | |||
| ANDA088058 - ABBVIE | |||||||
| VICODIN | ACETAMINOPHEN; HYDROCODONE BITARTRATE | TABLET;ORAL | 500MG;5MG | Discontinued | |||
| ANDA087853 - ABBVIE | |||||||
| ATROPINE AND DEMEROL | ATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.4MG/ML;50MG/ML | Discontinued | |||
| ANDA087848 - ABBVIE | |||||||
| ATROPINE AND DEMEROL | ATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.4MG/ML;100MG/ML | Discontinued | |||
| ANDA087847 - ABBVIE | |||||||
| ATROPINE AND DEMEROL | ATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.4MG/ML;75MG/ML | Discontinued | |||
| ANDA075729 - ABBVIE | |||||||
| FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER | FAMOTIDINE | INJECTABLE;INJECTION | 0.4MG/ML | Discontinued | |||
| ANDA075114 - ABBVIE | |||||||
| ACYCLOVIR | ACYCLOVIR SODIUM | INJECTABLE;INJECTION | EQ 50MG BASE/ML | Discontinued | |||
| ANDA074638 - ABBVIE | |||||||
| IOPAMIDOL-300 | IOPAMIDOL | INJECTABLE;INJECTION | 61% | Discontinued | |||
| ANDA071295 - ABBVIE | |||||||
| ATROPINE | ATROPINE | SOLUTION;INTRAMUSCULAR | EQ 2MG SULFATE/0.7ML | Discontinued | |||
| ANDA065025 - ABBVIE | |||||||
| CYCLOSPORINE | CYCLOSPORINE | SOLUTION;ORAL | 100MG/ML | Prescription | |||
| ANDA065003 - ABBVIE | |||||||
| GENGRAF | CYCLOSPORINE | CAPSULE;ORAL | 50MG | Discontinued | |||
| GENGRAF | CYCLOSPORINE | CAPSULE;ORAL | 100MG | Prescription | |||
| GENGRAF | CYCLOSPORINE | CAPSULE;ORAL | 25MG | Prescription | |||
| NDA050790 - ABBVIE | |||||||
| RESTASIS MULTIDOSE | CYCLOSPORINE | EMULSION;OPHTHALMIC | 0.05% | Prescription | |||
| RESTASIS | CYCLOSPORINE | EMULSION;OPHTHALMIC | 0.05% | Prescription | |||
| NDA050775 - ABBVIE | |||||||
| BIAXIN XL | CLARITHROMYCIN | TABLET, EXTENDED RELEASE;ORAL | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA050749 - ABBVIE | |||||||
| OMNICEF | CEFDINIR | FOR SUSPENSION;ORAL | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| OMNICEF | CEFDINIR | FOR SUSPENSION;ORAL | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA050739 - ABBVIE | |||||||
| OMNICEF | CEFDINIR | CAPSULE;ORAL | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA050698 - ABBVIE | |||||||
| BIAXIN | CLARITHROMYCIN | FOR SUSPENSION;ORAL | 125MG/5ML | Discontinued | |||
| BIAXIN | CLARITHROMYCIN | FOR SUSPENSION;ORAL | 250MG/5ML | Discontinued | |||
| BIAXIN | CLARITHROMYCIN | FOR SUSPENSION;ORAL | 187MG/5ML | Discontinued | |||
| NDA050697 - ABBVIE INC | |||||||
| BIAXIN XL | CLARITHROMYCIN | TABLET;ORAL | 500MG | Prescription | |||
| BIAXIN XL | CLARITHROMYCIN | TABLET;ORAL | 250MG | Prescription | |||
| NDA050662 - ABBVIE | |||||||
| BIAXIN | CLARITHROMYCIN | TABLET;ORAL | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| BIAXIN | CLARITHROMYCIN | TABLET;ORAL | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| ANDA040117 - ABBVIE | |||||||
| VICODIN HP | ACETAMINOPHEN; HYDROCODONE BITARTRATE | TABLET;ORAL | 660MG;10MG | Discontinued | |||
| NDA022567 - ABBVIE | |||||||
| VIIBRYD | VILAZODONE HYDROCHLORIDE | TABLET;ORAL | 10MG | Prescription | |||
| VIIBRYD | VILAZODONE HYDROCHLORIDE | TABLET;ORAL | 20MG | Prescription | |||
| VIIBRYD | VILAZODONE HYDROCHLORIDE | TABLET;ORAL | 40MG | Prescription | |||
| NDA022548 - ABBVIE | |||||||
| ZYMAXID | GATIFLOXACIN | SOLUTION/DROPS;OPHTHALMIC | 0.5% | Prescription | |||
| NDA022525 - ABBVIE | |||||||
| NAMENDA XR | MEMANTINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 7MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NAMENDA XR | MEMANTINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 14MG | Discontinued | |||
| NAMENDA XR | MEMANTINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 21MG | Discontinued | |||
| NAMENDA XR | MEMANTINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | 28MG | Discontinued | |||
| NDA022427 - ABBVIE | |||||||
| ACUVAIL | KETOROLAC TROMETHAMINE | SOLUTION/DROPS;OPHTHALMIC | 0.45% | Prescription | |||
| NDA022417 - ABBVIE | |||||||
| NORVIR | RITONAVIR | TABLET;ORAL | 100MG | Prescription | |||
| NDA022369 - ABBVIE | |||||||
| LATISSE | BIMATOPROST | SOLUTION/DROPS;TOPICAL | 0.03% | Prescription | |||
| NDA022315 - ABBVIE | |||||||
| OZURDEX | DEXAMETHASONE | IMPLANT;INTRAVITREAL | 0.7MG | Prescription | |||
| NDA022267 - ABBVIE INC | |||||||
| DEPAKOTE ER | DIVALPROEX SODIUM | TABLET, EXTENDED RELEASE; ORAL | 250MG | Prescription | |||
| DEPAKOTE ER | DIVALPROEX SODIUM | TABLET, EXTENDED RELEASE; ORAL | 500MG | Prescription | |||
| NDA022256 - ABBVIE | |||||||
| SAVELLA | MILNACIPRAN HYDROCHLORIDE | TABLET;ORAL | 12.5MG | Prescription | |||
| SAVELLA | MILNACIPRAN HYDROCHLORIDE | TABLET;ORAL | 25MG | Prescription | |||
| SAVELLA | MILNACIPRAN HYDROCHLORIDE | TABLET;ORAL | 100MG | Prescription | |||
| SAVELLA | MILNACIPRAN HYDROCHLORIDE | TABLET;ORAL | 50MG | Prescription | |||
| NDA022224 - ABBVIE | |||||||
| TRILIPIX | CHOLINE FENOFIBRATE | CAPSULE, DELAYED RELEASE;ORAL | EQ 45MG FENOFIBRIC ACID | Prescription | |||
| TRILIPIX | CHOLINE FENOFIBRATE | CAPSULE, DELAYED RELEASE;ORAL | EQ 135MG FENOFIBRIC ACID | Prescription | |||
| NDA022206 - ABBVIE | |||||||
| RAPAFLO | SILODOSIN | CAPSULE;ORAL | 4MG | Prescription | |||
| RAPAFLO | SILODOSIN | CAPSULE;ORAL | 8MG | Prescription | |||
| NDA022204 - ABBVIE | |||||||
| GELNIQUE | OXYBUTYNIN CHLORIDE | GEL;TRANSDERMAL | 10% (100MG/PACKET) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA022184 - ABBVIE | |||||||
| LUMIGAN | BIMATOPROST | SOLUTION/DROPS;OPHTHALMIC | 0.01% | Prescription | |||
| NDA022134 - ABBVIE | |||||||
| LASTACAFT | ALCAFTADINE | SOLUTION/DROPS;OPHTHALMIC | 0.25% | Over-the-counter | |||
| NDA021906 - ABBVIE | |||||||
| KALETRA | LOPINAVIR; RITONAVIR | TABLET;ORAL | 200MG;50MG | Prescription | |||
| KALETRA | LOPINAVIR; RITONAVIR | TABLET;ORAL | 100MG;25MG | Prescription | |||
| NDA021883 - ABBVIE | |||||||
| DALVANCE | DALBAVANCIN HYDROCHLORIDE | POWDER;INTRAVENOUS | EQ 500MG BASE/VIAL | Prescription | |||
| NDA021830 - ABBVIE | |||||||
| ASACOL HD | MESALAMINE | TABLET, DELAYED RELEASE;ORAL | 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA021794 - ABBVIE | |||||||
| ACZONE | DAPSONE | GEL;TOPICAL | 5% | Prescription | |||
| NDA021770 - ABBVIE | |||||||
| ALPHAGAN P | BRIMONIDINE TARTRATE | SOLUTION/DROPS;OPHTHALMIC | 0.1% | Prescription | |||
| NDA021656 - ABBVIE | |||||||
| TRICOR | FENOFIBRATE | TABLET;ORAL | 48MG | Discontinued | |||
| TRICOR | FENOFIBRATE | TABLET;ORAL | 145MG | Discontinued | |||
| NDA021606 - ABBVIE | |||||||
| ZEMPLAR | PARICALCITOL | CAPSULE;ORAL | 4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| ZEMPLAR | PARICALCITOL | CAPSULE;ORAL | 2MCG | Prescription | |||
| ZEMPLAR | PARICALCITOL | CAPSULE;ORAL | 1MCG | Prescription | |||
| NDA021528 - ABBVIE | |||||||
| ACULAR LS | KETOROLAC TROMETHAMINE | SOLUTION/DROPS;OPHTHALMIC | 0.4% | Prescription | |||
| NDA021513 - ABBVIE | |||||||
| ENABLEX | DARIFENACIN HYDROBROMIDE | TABLET, EXTENDED RELEASE;ORAL | EQ 7.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| ENABLEX | DARIFENACIN HYDROBROMIDE | TABLET, EXTENDED RELEASE;ORAL | EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA021487 - ABBVIE | |||||||
| NAMENDA | MEMANTINE HYDROCHLORIDE | TABLET;ORAL | 10MG | Prescription | |||
| NAMENDA | MEMANTINE HYDROCHLORIDE | TABLET;ORAL | 5MG | Prescription | |||
| NDA021402 - ABBVIE | |||||||
| SYNTHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Prescription | |||
| SYNTHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Prescription | |||
| SYNTHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Prescription | |||
| SYNTHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Prescription | |||
| SYNTHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Prescription | |||
| SYNTHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Prescription | |||
| SYNTHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Prescription | |||
| SYNTHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Prescription | |||
| SYNTHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Prescription | |||
| SYNTHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Prescription | |||
| SYNTHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Prescription | |||
| SYNTHROID | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | Prescription | |||
| NDA021398 - ABBVIE | |||||||
| COMBIGAN | BRIMONIDINE TARTRATE; TIMOLOL MALEATE | SOLUTION/DROPS;OPHTHALMIC | 0.2%;EQ 0.5% BASE | Prescription | |||
| NDA021365 - ABBVIE | |||||||
| LEXAPRO | ESCITALOPRAM OXALATE | SOLUTION;ORAL | EQ 5MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA021359 - ABBVIE | |||||||
| RECTIV | NITROGLYCERIN | OINTMENT;INTRA-ANAL | 0.4% | Prescription | |||
| NDA021323 - ABBVIE | |||||||
| LEXAPRO | ESCITALOPRAM OXALATE | TABLET;ORAL | EQ 5MG BASE | Prescription | |||
| LEXAPRO | ESCITALOPRAM OXALATE | TABLET;ORAL | EQ 10MG BASE | Prescription | |||
| LEXAPRO | ESCITALOPRAM OXALATE | TABLET;ORAL | EQ 20MG BASE | Prescription | |||
| NDA021275 - ABBVIE | |||||||
| LUMIGAN | BIMATOPROST | SOLUTION/DROPS;OPHTHALMIC | 0.03% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA021268 - ABBVIE | |||||||
| TEVETEN HCT | EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE | TABLET;ORAL | 600MG;12.5MG | Discontinued | |||
| TEVETEN HCT | EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE | TABLET;ORAL | 600MG;25MG | Discontinued | |||
| NDA021262 - ABBVIE | |||||||
| ALPHAGAN P | BRIMONIDINE TARTRATE | SOLUTION/DROPS;OPHTHALMIC | 0.15% | Prescription | |||
| NDA021252 - ABBVIE | |||||||
| CANASA | MESALAMINE | SUPPOSITORY;RECTAL | 1GM | Prescription | |||
| CANASA | MESALAMINE | SUPPOSITORY;RECTAL | 500MG | Discontinued | |||
| NDA021251 - ABBVIE | |||||||
| KALETRA | LOPINAVIR; RITONAVIR | SOLUTION;ORAL | 80MG/ML;20MG/ML | Prescription | |||
| NDA021226 - ABBVIE | |||||||
| KALETRA | LOPINAVIR; RITONAVIR | CAPSULE;ORAL | 133.3MG;33.3MG | Discontinued | |||
| NDA021203 - ABBVIE | |||||||
| TRICOR | FENOFIBRATE | TABLET;ORAL | 54MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| TRICOR | FENOFIBRATE | TABLET;ORAL | 160MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA021168 - ABBVIE | |||||||
| DEPAKOTE ER | DIVALPROEX SODIUM | TABLET, EXTENDED RELEASE;ORAL | EQ 250MG VALPROIC ACID | Prescription | |||
| DEPAKOTE ER | DIVALPROEX SODIUM | TABLET, EXTENDED RELEASE;ORAL | EQ 500MG VALPROIC ACID | Prescription | |||
| NDA020945 - ABBVIE | |||||||
| NORVIR | RITONAVIR | CAPSULE;ORAL | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA020822 - ABBVIE | |||||||
| CELEXA | CITALOPRAM HYDROBROMIDE | TABLET;ORAL | EQ 10MG BASE | Prescription | |||
| CELEXA | CITALOPRAM HYDROBROMIDE | TABLET;ORAL | EQ 40MG BASE | Prescription | |||
| CELEXA | CITALOPRAM HYDROBROMIDE | TABLET;ORAL | EQ 60MG BASE | Discontinued | |||
| CELEXA | CITALOPRAM HYDROBROMIDE | TABLET;ORAL | EQ 20MG BASE | Prescription | |||
| NDA020819 - ABBVIE | |||||||
| ZEMPLAR | PARICALCITOL | SOLUTION;INTRAVENOUS | 0.005MG/ML (0.005MG/ML) | Prescription | |||
| ZEMPLAR | PARICALCITOL | SOLUTION;INTRAVENOUS | 0.002MG/ML (0.002MG/ML) | Prescription | |||
| ZEMPLAR | PARICALCITOL | SOLUTION;INTRAVENOUS | 0.01MG/2ML (0.005MG/ML) | Prescription | |||
| NDA020738 - ABBVIE | |||||||
| TEVETEN | EPROSARTAN MESYLATE | TABLET;ORAL | EQ 300MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| TEVETEN | EPROSARTAN MESYLATE | TABLET;ORAL | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| TEVETEN | EPROSARTAN MESYLATE | TABLET;ORAL | EQ 600MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| BLA020725 - ABBVIE | |||||||
| CREON | PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) | CAPSULE, DELAYED RELEASE;ORAL | 60,000USP UNITS;12,000USP UNITS;38,000USP UNITS | Prescription | |||
| CREON | PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) | CAPSULE, DELAYED RELEASE;ORAL | 120,000USP UNITS;24,000USP UNITS;76,000USP UNITS | Prescription | |||
| CREON | PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) | CAPSULE, DELAYED RELEASE;ORAL | 15,000USP UNITS;3,000USP UNITS;9,500USP UNITS | Prescription | |||
| CREON | PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) | CAPSULE, DELAYED RELEASE;ORAL | 180,000USP UNITS;36,000USP UNITS;114,000USP UNITS | Prescription | |||
| CREON | PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) | CAPSULE, DELAYED RELEASE;ORAL | 30,000USP UNITS;6,000USP UNITS;19,000USP UNITS | Prescription | |||
| NDA020716 - ABBVIE | |||||||
| VICOPROFEN | HYDROCODONE BITARTRATE; IBUPROFEN | TABLET;ORAL | 7.5MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA020708 - ABBVIE ENDOCRINE INC | |||||||
| LUPRON DEPOT | LEUPROLIDE ACETATE | INJECTABLE;INJECTION | 11.25MG | Prescription | |||
| NDA020659 - ABBVIE | |||||||
| NORVIR | RITONAVIR | SOLUTION;ORAL | 80MG/ML | Discontinued | |||
| NDA020655 - ABBVIE | |||||||
| ALORA | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.05MG/24HR | Discontinued | |||
| ALORA | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.075MG/24HR | Discontinued | |||
| ALORA | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.1MG/24HR | Discontinued | |||
| ALORA | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.025MG/24HR | Discontinued | |||
| NDA020593 - ABBVIE | |||||||
| DEPACON | VALPROATE SODIUM | INJECTABLE;INJECTION | EQ 100MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA020591 - ABBVIE | |||||||
| TARKA | TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 2MG;180MG | Discontinued | |||
| TARKA | TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 4MG;240MG | Discontinued | |||
| TARKA | TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 1MG;240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| TARKA | TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 2MG;240MG | Discontinued | |||
| NDA020551 - ABBVIE | |||||||
| NIMBEX | CISATRACURIUM BESYLATE | INJECTABLE;INJECTION | EQ 2MG BASE/ML | Discontinued | |||
| NIMBEX PRESERVATIVE FREE | CISATRACURIUM BESYLATE | INJECTABLE;INJECTION | EQ 10MG BASE/ML | Discontinued | |||
| NIMBEX PRESERVATIVE FREE | CISATRACURIUM BESYLATE | INJECTABLE;INJECTION | EQ 2MG BASE/ML | Discontinued | |||
| NDA020528 - ABBVIE | |||||||
| MAVIK | TRANDOLAPRIL | TABLET;ORAL | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| MAVIK | TRANDOLAPRIL | TABLET;ORAL | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| MAVIK | TRANDOLAPRIL | TABLET;ORAL | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA020517 - ABBVIE ENDOCRINE INC | |||||||
| LUPRON DEPOT | LEUPROLIDE ACETATE | INJECTABLE;INJECTION | 30MG | Prescription | |||
| LUPRON DEPOT | LEUPROLIDE ACETATE | INJECTABLE;INJECTION | 45MG | Prescription | |||
| LUPRON DEPOT | LEUPROLIDE ACETATE | INJECTABLE;INJECTION | 22.5MG | Prescription | |||
| NDA020489 - ABBVIE | |||||||
| ANDRODERM | TESTOSTERONE | FILM, EXTENDED RELEASE;TRANSDERMAL | 2.5MG/24HR | Discontinued | |||
| ANDRODERM | TESTOSTERONE | FILM, EXTENDED RELEASE;TRANSDERMAL | 2MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| ANDRODERM | TESTOSTERONE | FILM, EXTENDED RELEASE;TRANSDERMAL | 4MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| ANDRODERM | TESTOSTERONE | FILM, EXTENDED RELEASE;TRANSDERMAL | 5MG/24HR | Discontinued | |||
| NDA020478 - ABBVIE | |||||||
| ULTANE | SEVOFLURANE | LIQUID;INHALATION | 100% | Prescription | |||
| NDA020381 - ABBVIE | |||||||
| NIASPAN | NIACIN | TABLET, EXTENDED RELEASE;ORAL | 375MG | Discontinued | |||
| NIASPAN | NIACIN | TABLET, EXTENDED RELEASE;ORAL | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NIASPAN | NIACIN | TABLET, EXTENDED RELEASE;ORAL | 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NIASPAN | NIACIN | TABLET, EXTENDED RELEASE;ORAL | 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NIASPAN TITRATION STARTER PACK | NIACIN | TABLET, EXTENDED RELEASE;ORAL | 375MG;500MG;750MG | Discontinued | |||
| NDA020263 - ABBVIE ENDOCRINE INC | |||||||
| LUPRON DEPOT-PED KIT | LEUPROLIDE ACETATE | POWDER;INTRAMUSCULAR | 7.5MG | Prescription | |||
| LUPRON DEPOT-PED KIT | LEUPROLIDE ACETATE | POWDER;INTRAMUSCULAR | 3.75MG,7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| LUPRON DEPOT-PED KIT | LEUPROLIDE ACETATE | POWDER;INTRAMUSCULAR | 7.5MG,7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| LUPRON DEPOT-PED KIT | LEUPROLIDE ACETATE | POWDER;INTRAMUSCULAR | 11.25MG | Prescription | |||
| LUPRON DEPOT-PED KIT | LEUPROLIDE ACETATE | POWDER;INTRAMUSCULAR | 15MG | Prescription | |||
| LUPRON DEPOT-PED KIT | LEUPROLIDE ACETATE | POWDER;INTRAMUSCULAR | 11.25MG | Prescription | |||
| LUPRON DEPOT-PED KIT | LEUPROLIDE ACETATE | POWDER;INTRAMUSCULAR | 30MG | Prescription | |||
| LUPRON DEPOT-PED KIT | LEUPROLIDE ACETATE | POWDER;INTRAMUSCULAR | 45MG | Prescription | |||
| NDA020200 - ABBVIE | |||||||
| NALBUPHINE HYDROCHLORIDE | NALBUPHINE HYDROCHLORIDE | INJECTABLE;INJECTION | 1.5MG/ML | Discontinued | |||
| NDA020098 - ABBVIE | |||||||
| MIVACRON | MIVACURIUM CHLORIDE | SOLUTION;INTRAVENOUS | EQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| MIVACRON | MIVACURIUM CHLORIDE | SOLUTION;INTRAVENOUS | EQ 10MG BASE/5ML (EQ 2MG BASE/ML) | Discontinued | |||
| MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER | MIVACURIUM CHLORIDE | INJECTABLE;INJECTION | EQ 50MG BASE/100ML | Discontinued | |||
| MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER | MIVACURIUM CHLORIDE | INJECTABLE;INJECTION | EQ 0.5MG BASE/ML | Discontinued | |||
| MIVACRON | MIVACURIUM CHLORIDE | SOLUTION;INTRAVENOUS | EQ 20MG BASE/10ML (EQ 2MG BASE/ML) | Discontinued | |||
| BLA020032 - ABBVIE | |||||||
| SURVANTA | BERACTANT | SUSPENSION;INTRATRACHEAL | 25MG/ML | Prescription | |||
| NDA020011 - ABBVIE ENDOCRINE INC | |||||||
| LUPRON DEPOT | LEUPROLIDE ACETATE | INJECTABLE;INJECTION | 3.75MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| LUPRON DEPOT | LEUPROLIDE ACETATE | INJECTABLE;INJECTION | 3.75MG | Prescription | |||
| NDA019946 - ABBVIE | |||||||
| NUROMAX | DOXACURIUM CHLORIDE | INJECTABLE;INJECTION | EQ 1MG BASE/ML | Discontinued | |||
| NDA019943 - ABBVIE ENDOCRINE INC | |||||||
| LUPRON DEPOT | LEUPROLIDE ACETATE | INJECTABLE; INJECTION | 3.75MG | Prescription | |||
| NDA019732 - ABBVIE ENDOCRINE INC | |||||||
| LUPRON DEPOT | LEUPROLIDE ACETATE | INJECTABLE;INJECTION | 7.5MG | Prescription | |||
| NDA019700 - ABBVIE | |||||||
| ACULAR | KETOROLAC TROMETHAMINE | SOLUTION/DROPS;OPHTHALMIC | 0.5% | Prescription | |||
| NDA019680 - ABBVIE | |||||||
| DEPAKOTE | DIVALPROEX SODIUM | CAPSULE, DELAYED REL PELLETS;ORAL | EQ 125MG VALPROIC ACID | Prescription | |||
| NDA019304 - ABBVIE | |||||||
| TRICOR (MICRONIZED) | FENOFIBRATE | CAPSULE;ORAL | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| LIPIDIL | FENOFIBRATE | CAPSULE;ORAL | 100MG | Discontinued | |||
| TRICOR (MICRONIZED) | FENOFIBRATE | CAPSULE;ORAL | 134MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| TRICOR (MICRONIZED) | FENOFIBRATE | CAPSULE;ORAL | 67MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA019216 - ABBVIE | |||||||
| FML FORTE | FLUOROMETHOLONE | SUSPENSION/DROPS;OPHTHALMIC | 0.25% | Prescription | |||
| NDA019204 - ABBVIE | |||||||
| CARTROL | CARTEOLOL HYDROCHLORIDE | TABLET;ORAL | 5MG | Discontinued | |||
| CARTROL | CARTEOLOL HYDROCHLORIDE | TABLET;ORAL | 10MG | Discontinued | |||
| CARTROL | CARTEOLOL HYDROCHLORIDE | TABLET;ORAL | 2.5MG | Discontinued | |||
| NDA019183 - ABBVIE | |||||||
| CARAFATE | SUCRALFATE | SUSPENSION;ORAL | 1GM/10ML | Prescription | |||
| NDA019010 - ABBVIE ENDOCRINE INC | |||||||
| LUPRON | LEUPROLIDE ACETATE | SOLUTION;SUBCUTANEOUS | 14MG/2.8ML (1MG/0.2ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA018874 - ABBVIE | |||||||
| CALCIJEX | CALCITRIOL | INJECTABLE;INJECTION | 0.001MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| CALCIJEX | CALCITRIOL | INJECTABLE;INJECTION | 0.002MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA018723 - ABBVIE | |||||||
| DEPAKOTE | DIVALPROEX SODIUM | TABLET, DELAYED RELEASE;ORAL | EQ 500MG VALPROIC ACID | Prescription | |||
| DEPAKOTE | DIVALPROEX SODIUM | TABLET, DELAYED RELEASE;ORAL | EQ 125MG VALPROIC ACID | Prescription | |||
| DEPAKOTE | DIVALPROEX SODIUM | TABLET, DELAYED RELEASE;ORAL | EQ 250MG VALPROIC ACID | Prescription | |||
| NDA018450 - ABBVIE | |||||||
| NITROPRESS | SODIUM NITROPRUSSIDE | INJECTABLE;INJECTION | 50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA018333 - ABBVIE | |||||||
| CARAFATE | SUCRALFATE | TABLET;ORAL | 1GM | Prescription | |||
| NDA018279 - ABBVIE | |||||||
| K-TAB | POTASSIUM CHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 10MEQ **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| K-TAB | POTASSIUM CHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 8MEQ **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| K-TAB | POTASSIUM CHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 20MEQ **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA018117 - ABBVIE | |||||||
| AZMACORT | TRIAMCINOLONE ACETONIDE | AEROSOL, METERED;INHALATION | 0.1MG/INH | Discontinued | |||
| NDA018082 - ABBVIE | |||||||
| DEPAKENE | VALPROIC ACID | SYRUP;ORAL | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA018081 - ABBVIE | |||||||
| DEPAKENE | VALPROIC ACID | CAPSULE;ORAL | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA017100 - ABBVIE | |||||||
| PRED MILD | PREDNISOLONE ACETATE | SUSPENSION/DROPS;OPHTHALMIC | 0.12% | Prescription | |||
| NDA017011 - ABBVIE | |||||||
| PRED FORTE | PREDNISOLONE ACETATE | SUSPENSION/DROPS;OPHTHALMIC | 1% | Prescription | |||
| NDA016851 - ABBVIE | |||||||
| FML | FLUOROMETHOLONE | SUSPENSION/DROPS;OPHTHALMIC | 0.1% | Prescription | |||
| NDA012524 - ABBVIE | |||||||
| ENDURON | METHYCLOTHIAZIDE | TABLET;ORAL | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| ENDURON | METHYCLOTHIAZIDE | TABLET;ORAL | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA012418 - ABBVIE | |||||||
| AKINETON | BIPERIDEN LACTATE | INJECTABLE;INJECTION | 5MG/ML | Discontinued | |||
| NDA012302 - ABBVIE | |||||||
| CHOLOXIN | DEXTROTHYROXINE SODIUM | TABLET;ORAL | 2MG | Discontinued | |||
| CHOLOXIN | DEXTROTHYROXINE SODIUM | TABLET;ORAL | 4MG | Discontinued | |||
| CHOLOXIN | DEXTROTHYROXINE SODIUM | TABLET;ORAL | 1MG | Discontinued | |||
| CHOLOXIN | DEXTROTHYROXINE SODIUM | TABLET;ORAL | 6MG | Discontinued | |||
| NDA012148 - ABBVIE | |||||||
| ORETICYL 25 | DESERPIDINE; HYDROCHLOROTHIAZIDE | TABLET;ORAL | 0.125MG;25MG | Discontinued | |||
| ORETICYL FORTE | DESERPIDINE; HYDROCHLOROTHIAZIDE | TABLET;ORAL | 0.25MG;25MG | Discontinued | |||
| ORETICYL 50 | DESERPIDINE; HYDROCHLOROTHIAZIDE | TABLET;ORAL | 0.125MG;50MG | Discontinued | |||
| NDA012003 - ABBVIE | |||||||
| AKINETON | BIPERIDEN HYDROCHLORIDE | TABLET;ORAL | 2MG | Discontinued | |||
| NDA011971 - ABBVIE | |||||||
| ORETIC | HYDROCHLOROTHIAZIDE | TABLET;ORAL | 25MG | Discontinued | |||
| ORETIC | HYDROCHLOROTHIAZIDE | TABLET;ORAL | 50MG | Discontinued | |||
| NDA010796 - ABBVIE | |||||||
| HARMONYL | DESERPIDINE | TABLET;ORAL | 0.1MG | Discontinued | |||
| HARMONYL | DESERPIDINE | TABLET;ORAL | 0.25MG | Discontinued | |||
| NDA010599 - ABBVIE | |||||||
| TRAL | HEXOCYCLIUM METHYLSULFATE | TABLET;ORAL | 25MG | Discontinued | |||
| NDA010021 - ABBVIE | |||||||
| PLACIDYL | ETHCHLORVYNOL | CAPSULE;ORAL | 500MG | Discontinued | |||
| PLACIDYL | ETHCHLORVYNOL | CAPSULE;ORAL | 100MG | Discontinued | |||
| PLACIDYL | ETHCHLORVYNOL | CAPSULE;ORAL | 200MG | Discontinued | |||
| PLACIDYL | ETHCHLORVYNOL | CAPSULE;ORAL | 750MG | Discontinued | |||
| NDA008370 - ABBVIE | |||||||
| BENTYL PRESERVATIVE FREE | DICYCLOMINE HYDROCHLORIDE | INJECTABLE;INJECTION | 10MG/ML | Discontinued | |||
| BENTYL | DICYCLOMINE HYDROCHLORIDE | INJECTABLE;INJECTION | 10MG/ML | Discontinued | |||
| NDA008322 - ABBVIE | |||||||
| GEMONIL | METHARBITAL | TABLET;ORAL | 100MG | Discontinued | |||
| NDA007707 - ABBVIE | |||||||
| PHENURONE | PHENACEMIDE | TABLET;ORAL | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
| NDA006905 - ABBVIE | |||||||
| NORISODRINE | ISOPROTERENOL SULFATE | POWDER;INHALATION | 25% | Discontinued | |||
| NORISODRINE | ISOPROTERENOL SULFATE | POWDER;INHALATION | 10% | Discontinued | |||
| NDA006800 - ABBVIE | |||||||
| PARADIONE | PARAMETHADIONE | CAPSULE;ORAL | 150MG | Discontinued | |||
| PARADIONE | PARAMETHADIONE | CAPSULE;ORAL | 300MG | Discontinued | |||
| PARADIONE | PARAMETHADIONE | SOLUTION;ORAL | 300MG/ML | Discontinued | |||
| NDA006044 - ABBVIE | |||||||
| DIASONE SODIUM | SULFOXONE SODIUM | TABLET, DELAYED RELEASE;ORAL | 165MG | Discontinued | |||
| NDA005932 - ABBVIE | |||||||
| AMINOSOL 5% | PROTEIN HYDROLYSATE | INJECTABLE;INJECTION | 5% | Discontinued | |||
| NDA005856 - ABBVIE | |||||||
| TRIDIONE | TRIMETHADIONE | CAPSULE;ORAL | 300MG | Discontinued | |||
| TRIDIONE | TRIMETHADIONE | SOLUTION;ORAL | 200MG/5ML | Discontinued | |||
| TRIDIONE | TRIMETHADIONE | TABLET;ORAL | 150MG | Discontinued | |||
| NDA005545 - ABBVIE | |||||||
| DICUMAROL | DICUMAROL | TABLET;ORAL | 25MG | Discontinued | |||
| DICUMAROL | DICUMAROL | TABLET;ORAL | 50MG | Discontinued | |||
| DICUMAROL | DICUMAROL | TABLET;ORAL | 100MG | Discontinued | |||
| NDA004125 - ABBVIE | |||||||
| SULFADIAZINE | SULFADIAZINE | TABLET;ORAL | 300MG | Discontinued | |||